Iron

Rockwell Medical Inc. announced the FDA has recently accepted the company’s new drug application for its IV formulation of Triferic with a Prescription Drug User Fee Act date set for March 28, 2020.

In this video, Daniel W. Coyne, MD, professor of medicine in the nephrology/internal medicine division, director of the medical multispecialty outpatient group at the Center for Advanced Medicine and director of hemodialysis at the Chromalloy American Kidney Center at Washington University School of Medicine in St. Louis, offers new residents advice when managing anemia in patients with chronic kidney disease.